TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/24 18:50 | 4/2/24 | XLO | Xilio Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P.d | 369 | 0.7600 | 0 | 485 | 7 | 7,345 | D | |||||||||||||||
2/13/24 17:48 | 2/12/24 | KYTX | Kyverna Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P.d | 20,020 | 22.00 | 0 | 910 | 28 | 4,126 | D | |||||||||||||||
1/31/24 17:00 | 1/29/24 | RCUS | Arcus Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 320,000 | 21.00 | 0 | 15,238 | 103 | 30,061 | D | |||||||||||||||
6/30/23 15:12 | 6/28/23 | RCUS | Arcus Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 19,453 | 19.26 | 0 | 1,010 | 7 | 14,823 | D | |||||||||||||||
6/28/23 17:17 | 6/27/23 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 10,991 | 3.75 | 0 | 2,931 | 21 | 16,635 | D | |||||||||||||||
2/2/21 16:52 | 1/31/21 | RCUS | Arcus Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences Inc | CA | T | P | 220,350 | 39.00 | 0 | 5,650 | 68 | 13,913 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |